Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells

December 1, 2022 11:28 am Published by

Melendez, A. V., R. M. Velasco Cardenas, S. Lagies, J. Strietz, L. Siukstaite, O. S. Thomas, J. Tomisch, W. Weber, B. Kammerer, W. Romer, and S. Minguet. 2022. Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells. Cell Mol Life Sci 79: 513. doi: 10.1007/s00018-022-04524-7.

Categorised in:

This post was written by Heike Ufheil